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Abstract

ASSESSING FEASIBILITY AND EFFECTIVENESS OF PEDIATRIC DENTAL
PROVIDER’S ROLE IN ORAL HEALTH AND PREVENTION EDUCATION IN THE CARE
OF CHILDREN WITH LEUKEMIA
By: Hannah Rustin, DMD
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
in Dentistry at Virginia Commonwealth University.
Virginia Commonwealth University, 2018
Thesis Advisors:
William Dahlke, DMD
Associate Professor, Chair of Department of Pediatric Dentistry
Frances Austin, MD
Assistant Professor, Department of Pediatrics, Division of Hematology Oncology
Purpose: Pediatric dentists could serve a role in care of children with leukemia. Oral sequelae of
cancer therapies are well documented. The purpose of this study is to assess the feasibility and
effectiveness of the pediatric dentist in the care of patients with leukemia.
Methods: Pediatric Hematology and Oncology at Virginia Commonwealth University was
educated on the proposed protocol and administered a questionnaire to assess feasibility of
implementing prevention education by the pediatric dentist. Patients were randomized into two
groups at diagnosis: one receiving current oral health protocol and those receiving one-on-one
prevention education with the pediatric dentist at three points during treatment. Data was
collected through clinical intraoral examination and salivary sample.
Results: All respondents reported this would address a known problem for patients. They agreed
it is feasible and would be a valuable addition to care of these patients. Subject recruitment is
ongoing for the effectiveness portion of the study.
Conclusion: The addition of the pediatric dentist to the pediatric oncology care team is warranted
and feasible.

Introduction

Leukemia is the most common pediatric malignancy, accounting for approximately 30%
of cancers diagnosed in children under the age of 15.1,2 Acute lymphoblastic leukemia (ALL) is
most common pediatric leukemia; accounting for 75%of all new leukemia diagnoses and 25% of
malignancies in childhood.2,3 Most other cases are acute myeloid leukemia. Leukemia is
characterized by uncontrolled reproduction of hematopoietic stem cells in the bone marrow and
then diffusion of these cells into peripheral blood.4 The highest incidence of leukemia in children
is between 2 and 5 years of age.2 Pediatric patients undergo extensive courses of therapy lasting
2 to 3 years, which has increased survival rates. Pediatric patients experience many wellidentified acute oral sequelae during treatment for leukemia, and survivors continue to be at risk
for dental abnormalities and complications associated with chemotherapy.5
There are multiple identified oral manifestations that can be attributed to the malignancy
or secondary to cancer therapies. Hong et al reported a mean incidence of 54% of children
experiencing acute oral sequelae, with varying percentages between 31-93% reported by others.6
Oral mucositis is a commonly reported painful complication resulting from the cytotoxic effects
of cancer therapies on epithelial and subepithelial tissues.1,2,7 The lesions first present as an
erythematous plaque and progress to ulcerations.2 Gingivitis was noted more often in one study
in children with ALL than healthy children in the control group. 3 Gingivitis was the most
1

common oral manifestation, affecting over 90%of patients undergoing therapy for ALL in a
study by Ponce-Torres et al.7 Oral petechiae has been observed in 32% of patients.6 Oral mucosal
infections due to various organisms have also been reported. 1,2,7,8A 2009 literature review
reported the mean incidence of oral candidiasis to be 15%. The reported incidence of herpes
simplex virus infections was 8%, pseudomonas infection of lips was 4 percent, and necrotizing
ulcerative gingivitis was 2%. 6 Xerostomia is also commonly reported. 1,2,7,8
Pediatric oncology patients are also at an increased risk for systemic infections due to
immunosuppression. It has been reported that 25-54% of incidences of septicemia in patients
being treated for cancer with neutropenia seem to originate from bacteria that colonize the oral
cavity.9 Elad et al concluded that dental treatment preceding chemotherapy is supported for
reduction of disseminated infections during subsequent periods of immunosuppression. Based
on data analysis in this study, foregoing dental treatment prior to the initiation of chemotherapy
increased the probability of mortality due to odontogenic infection for an additional 1.8 of every
1000 patients.10
In addition to the negative effects observed during a child’s active treatment stage,
pediatric oncology patients are at risk for long-term effects of chemotherapy on dental health and
development. Chemotherapy is unfortunately nonselective, interfering with DNA synthesis and
replication, RNA transcription, and cytoplasmic transport mechanisms to destroy both actively
proliferating malignant and healthy cells.3 Younger age during treatment has been associated
with increased abnormalities of dental development as the effects of chemotherapy are
intensified when dental cells are rapidly multiplying.5 Formation of the primary second molar,
the last primary tooth to erupt, is not complete until age 3. Calcification of premolars and second
molars begins between 2-3 years of age, and crown enamel of most of the permanent dentition is
2

completed between the ages of 4 and 8. Both of these processes occur in the age range that most
pediatric patients with leukemia are undergoing therapy. After eruption of the permanent
dentition, root formation is not completed for 2 to 3 years.11 Agenesis, microdontia, short and
tapering roots were observed more often in children with ALL than healthy controls;
hypomineralization or hypomaturation of enamel and taurodontism were also noted.12 Nemeth et
al identified root malformations as the most frequent developmental disturbance, occurring in
over 50% of patients.13
Increased risk for dental caries has been identified in children who are undergoing or
have undergone treatment for cancer. Hegde et al. noted that DMFT (decayed, missing, filled
teeth) scores were significantly higher in children with ALL as compared to healthy controls.1
Ponce-Torres et al. noted dental caries in 82% of patients.7 Although increased DMFT was not
observed by Yang et al, the number of untreated carious surfaces of primary teeth was increased
in children with ALL.9 Olszewska and Mielnik-Blaszczak concluded that caries activity
increases in children receiving antineoplastic treatment due to a significant increase in the
quantity of cariogenic bacteria in saliva during episodes of subsequent neutropenia.14 Wogelius
et al concluded that childhood cancer and cancer therapy were associated with increased caries
risk, but that risk may decrease with longer follow up.15 The weighted prevalence of dental caries
amongst survivors was highest among patients that underwent chemotherapy only as compared
to those who underwent radiation or chemotherapy and radiation in one systematic review. It was
suggested that this may be due to different oral care management for patients preparing for
radiation therapy versus chemotherapy in cancer treatment centers.16 Xerostomia and levels of
cariogenic bacteria, which are also acute-phase oral sequelae, are increased in survivors as well.5
Research has demonstrated that formation of dental caries is a multifactorial process
3

involving aciduric and acidogenic bacteria, fermentable carbohydrate exposure, and host factors
including teeth and saliva.17 Primary teeth are more vulnerable to rapid progression of caries due
to thinner enamel and dentin layers and larger pulp chambers.18 The caries balance concept is
important to prevention. The progression or reversal of carious lesions depends on eliminating
caries-promoting factors and maximizing caries-protective factors. Food preferences and
tolerances may shift to highly cariogenic foods during therapy. Supplements with added sugar
may be necessary to maintain weight and liquid medications high in sucrose may be prescribed
frequently.16 It has been well-established that patients experience decreased salivary flow rate
secondary to salivary gland hypoplasia during chemotherapy.3 This results in decreased buffering
capacity and promotes a caries active state in the oral cavity. The mean salivary pH of patients
undergoing chemotherapy was 6.5 and 7.5 in control patients.1 Vomiting may also temporarily
result in decreased intraoral pH. Compliance with oral hygiene may become more difficult and
decrease with nausea, mucositis pain, and other complications secondary to therapy.1,19
Therefore, optimizing caries-protective factors is of utmost importance for the pediatric oncology
patient. Caries progression can be reduced or avoided with identification of disease indicators
and individualized preventive practices.20
The importance of addressing the oral health of oncology patients during treatment and as
a survivor has been identified.2,7,8,19,21,22 Preventive practices have been shown to improve oral
and dental outcomes for patients following chemotherapy.15 However, a survey of supportive
health care providers found that cohesive medical and dental services were only found in 25 % of
the respondents’ institutions. 22 Although a majority of responding institutions incorporated
dental consultations and oral health education at diagnosis, only half provided care during
treatment. 22 Another survey of National Cancer Institute-designated comprehensive care centers
4

found that only 19% of responding centers provided an oral assessment for all patients and 63%
requested dental consultation for those with identified pathology or complaints. Also, 56% of
centers did not have a dental department and only one third of patients undergoing chemotherapy
were provided oral care and prevention education. 23 After treatment, research has also shown
that dental utilization practices of survivors is suboptimal.24
Multiple barriers have been suggested as challenges to oral health and prevention
education for the oncology patient. Gaps in knowledge, reliance on tradition, inconsistent or
absent oral assessment, diverse oral care regimens and practices, administrative and clinical
issues, and lack of interdisciplinary collaboration have been discussed as obstacles to the
implementation of oral health care standards. A more fundamental barrier is the lack of an
accepted universal standard. There is little agreement amongst experts in all disciplines
concerned with oral care of the oncology patient in regards to tools for assessment of risk, most
appropriate oral care instructions and dental chemotherapeutic agents, clinical outcomes, and
protocols.25 Dentists may also receive varying levels of training in the treatment of patients
undergoing cancer therapies resulting in a limited number of dental providers comfortable and
confident in providing oral health care and education to this unique population. 8,21 Another
proposed barrier involves lack of financial resources for provision of dental services. 8
The purpose of this study is to increase oral health and prevention education for pediatric
patients with leukemia at Virginia Commonwealth University Medical Center (VCU) and to
determine if the pediatric dental provider’s role is feasible and effective in reducing cariespromoting factors and optimizing caries-protective factors.

5

Aim 1: Develop a protocol for interdisciplinary care of pediatric patients with leukemia that
increases oral health and prevention education with the inclusion of a pediatric dental provider.
Aim 2: Assess the perceived feasibility of the protocol by current providers in the Department of
Pediatric Hematology and Oncology at VCU
Aim 3: Assess the effectiveness of the increased oral health and prevention counseling on a
sample of pediatric patients with leukemia.
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Methods

This study was approved by the Massey Cancer Center Protocol Review and Monitoring
Committee Cancer Prevention and Control Subcommittee and the Institutional Review Board of
VCU (IRB HM20006475), Richmond Virginia.
Effectiveness Assessment
Subject Population
The targeted population of this study was pediatric patients ages 3 to 12 who have been
recently diagnosed with leukemia (ALL and AML). This age range is representative of the
pediatric patient with leukemia. Although the peak incidence occurs during ages 2 to 5, the age
for inclusion was increased to 3 due to limited cooperation of younger patients. Subjects were
patients of VCU Medical Center Pediatric Hematology and Oncology Clinic.
Research Design
Patients treated for leukemia at VCU are currently receiving oral hygiene instruction at
diagnosis. In this study, patients were and were be randomized into 2 groups at diagnosis: 1)
receive current prevention education and 2) receive one-on-one prevention education and
counseling with a pediatric dental resident.
Standard oral health protocol at VCU involves an annual lecture given by a Pediatric
Hematology and Oncology Attending discussing the importance of oral hygiene, current
7

standards of dental care for patients undergoing oncologic care, and dental complications of
oncologic care. A similar lecture is given to the pediatric dental residents. Dental residents are
called with all new diagnoses and perform a baseline examination and identify immediate needs.
Plans are made for children who have urgent dental needs at the beginning of therapy. For nonurgent dental needs the oncology team and dental team discuss with family and make plans for
dental care later in therapy. The oncology team provides education about the need for a regular
oral health routine at diagnosis. Family are given fliers with pictograms describing proper
brushing, use of mouth wash, and common oral complications during therapy. Families and
patients are also given a bottle and prescription for chlorhexidine gluconate 0.12% rinse.
Currently the Pediatric Hematology and Oncology Attending is tracking the compliance of and
how well her colleagues are documenting ongoing oral hygiene care. For patients randomized
into the second group, counseling with the hematology and oncology attending and pediatric
dental resident will be in addition to standard protocol. Oral hygiene and care recommendations
are reviewed at diagnosis, 16 weeks, and 32 weeks. Provided recommendations are based on
American Academy of Pediatric Dentistry’s guideline developed after systematic literature
review and the National Institute of Dental and Craniofacial Research’s Cancer Treatment and
Oral Health guidelines for providers and patients.26,27
As caries risk is dynamic, a questionnaire was administered for each patient at diagnosis
and future points of data collection to perform caries risk assessment. Caries incidence,
Streptococcus mutans, sobrinus, and sanguinis levels, salivary flow rate, and salivary pH was
assessed at week one (diagnosis), week 16 or start of interim maintenance therapy whichever
comes second, week 32 or beginning of maintenance therapy whichever is later for all patients
enrolled in the study. Data was collected through a clinical intraoral examination and salivary
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sample. Data collected was used to assess the effect of increased prevention education on factors
of importance in caries formation.
Data was collected and stored in a password protected laptop which was kept in a locked
file cabinet in the Department of Hematology and Oncology. Patients were assigned a number
from a randomization list and stored in a password- protected computer. All samples collected
were labeled with that unique patient identifying number and no personal identifiers.
Sepsis is not uncommon during the first nine months of leukemic therapy. Bacteria
isolates collected at induction, interim maintenance, and beginning of maintenance were stored.
In the event of a disseminated infection, researchers will review the bacteria isolated from the
disseminated infection and determine its consistency with one of colonies previously collected
during data collection.
Exclusions of Special Populations


> Age 12



Full permanent dentition



Primary language is not English



Children in the custody of the state with no parent or legal guardian present to sign
consent

Sample Size
The target sample size for the pilot study was 30 participants. Participants were
randomized into 2 groups-fifteen in each group. A randomization list was created using a random
number generator and each subject enrolled in the study was assigned to the corresponding
treatment in the list. All were assigned consecutively and allocation was equal.
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In terms of statistical power, a sample size of 30 will be able to detect a significant
difference in the groups from baseline to follow-up with 80% power and a 0.05 significance level
if the scores for the treatment group are better than 80% of the control group. This is based on a
rank-sum test with n=15 per group, alpha=0.05, power=80%.28 Using a t-test, a sample size of 15
per group will be able to detect an effect size of 1.06 (ratio of different in means to within group
standard deviation) with 80% power and significance level of 0.05.29 Because this is a pilot
study, we were primarily powering the difference from baseline to final follow-up. We hope to
use data from this study to power a repeated measures analysis in a larger study.
Enrollment Procedures
Potential subjects were approached at diagnosis. The Pediatric Hematology Oncology
fellows and attending physicians discuss enrollment with the family and patient in a private and
quiet room in the Pediatric Hematology Oncology clinic or in the hospital. Physician, family, and
patient discuss risks and benefits of enrollment. The letter of consent was administered and
collected at this appointment. Assent was obtained from potential participants of appropriate age.
Explanation of Measured Variables and Instruments
Caries risk assessment
A caries risk assessment involves discussion with parents concerning dietary habits, oral
hygiene, and other caries-promoting and caries-protective behaviors and clinical examination of
the pediatric patient. Information gathered on disease indicators (white spot lesions, cavitated
lesions), risk factors (plaque, gingivitis, xerostomia), and protective factors (fluoride) is used to
determine caries risk. Once caries risk is determined, direction was provided for implementation
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of prevention practices. A questionnaire was administered at each point in data collection to help
in assessment of caries risk.
Merged ICDAS
The concept of International Caries Detection and Assessment System (ICDAS) is based
on the idea that a standardized, evidence-based system for detecting caries will result in
improved diagnosis and clinical management. The Merged ICDAS format involves describing
enamel as sound tooth (0), visual change in enamel (A), moderate decay (B), and extensive
decay (C). Activity will be described as active lesions (+) or arrested lesions (-).30
Salivary flow rate
Salivary flow rate serves as an indicator of host potential for biologic repair. Stimulated salivary
flow rate was measured utilizing pre-weighed cotton rolls. Patients were asked to saturate a
cotton roll over one minute by chewing. Tubes were centrifuged for two minutes at 1,000 X g to
collect saliva. Saliva was transferred to dose cup with micropipette. Dose cups were weighed
prior to and after data collection. The change in weight in grams were converted to mL of saliva
collected. Density of saliva is approximately 1g/mL. The obtained volume was divided by
collection time to provide salivary flow rate in mL/min. 3
Salivary pH
Salivary pH was measured from saliva sample collected for salivary flow rate after flow rate was
determined with 5.5-8.0 litmus paper. Fifty microliters of saliva were measured with pipette.
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Bacteria known to be involved in the caries process are aciduric and acidogenic. Therefore,
lower pH may indicate higher presence of cariogenic bacteria.
Streptococcus mutans, streptococcus sobrinus, and streptococcus sanguinis
Streptococcus mutans and sobrinus are two bacterial species that represent bacterial
challenge and serve as indicators of a caries-promoting environment. Streptococcus sanguinis is
a health-associated commensal. Samples were collected from the buccal surface of most
posterior maxillary right tooth and maxillary left tooth at each point of data collection. Samples
from most posterior maxillary right tooth were analyzed with qPCR to quantify levels of
Streptococcus mutans, sobrinus, and sanguinis. Samples from the most posterior maxillary left
tooth were stored at -70 degrees Celsius for comparison to bacteria isolated in the event of
disseminated infection. All specimens collected were analyzed in the Phillips Institute for Oral
Health Research at VCU.
Feasibility Assessment

Members of the VCU Pediatric Hematology Oncology Clinic were presented details of
the aforementioned protocol and given a questionnaire to assess their perceptions and get
feedback (Appendix 1). The items addressed the potential benefit to the patient and the burden
on the providers and allowed for respondents to indicate any potential barriers for implementing
the protocol.
Data Analysis
Results from the feasibility questionnaire were described using summary statistics
(counts and percentages). For the effectiveness portion of the study, changes in continuous,
normally distributed measures from diagnosis to follow-up visits were assessed using t-tests.
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Changes from baseline to follow-up in caries risk (and any other non-normally distributed
measures) were assessed using a nonparametric rank-sum test. If possible, repeated measures
ANOVA will be used to account for all three time points (baseline, 16 weeks, 32 weeks) but
given the limited sample size and nature of this pilot study, our primary analyses will be on the
change from baseline to each follow-up.
.
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Results

Feasibility Results
A total of 13 of the 15 included providers completed the questionnaire (response rate:
86.67%). Prior to completing the questionnaire, respondents received education of the proposed
role of the pediatric dentist, inclusion criteria for the study, and supplemental education
materials. Respondents were asked to indicate their agreement with statements regarding the
feasibility, importance, and implementation of the proposed protocol using a scale from Strong
Disagree to Strongly Agree (scored as -2 through 2 by 1). For the feasibility of the protocol, the
average response was 1.4 (between Agree and Strongly Agree) and the responses ranged from
Neutral (n=1) to Strongly Agree (n=6). The importance of addressing oral health during
oncology treatment was rated on average 1.7 (between Agree and Strongly Agree), with 10
respondents strongly agreeing and 3 agreeing. When asked if the addition of the protocol would
be a valuable addition to the patients’ care, 8 respondents strongly agreed and 5 agreed (average
agreement: 1.6). Results are given in Table 1.
A set of 7 possible strengths were presented and respondents were asked to indicate which they
felt were strengths of the proposed protocol. The complete list is given in Table 2/Figure 1. All
respondents indicated that the protocol addresses a known problem for the patients (n=13,
100%). Other highly indicated strengths were increasing parent and patient knowledge (n=11,
85%) and the interdisciplinary addition of the pediatric dentist to the patient care team (n=11,
14

85%). Roughly 75% felt the protocol would be simple to implement (n=10, 77%) and would
improve patient quality of life (n=10, 77%). Sixty-two percent (8 of 13) felt there would be low
burden on the current providers to implement.
A set of 6 possible weaknesses were presented and respondents were asked to indicate
which they felt were weaknesses of the proposed protocol. The complete list is given in Table 3.
Over half of the respondents indicated that they would need more training before full
implementation of the protocol (n=7, 54%). No one indicated the burden it would place on
current providers or that it would have a low impact on the patients as possible weaknesses.
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Discussion

As leukemia is the most common pediatric malignancy and oral sequelae are noted during
therapy and in survivors, pediatric dentists should serve an important role in multidisciplinary care
of these children. Acute and long-term oral sequelae are well-documented in children receiving
cancer therapies, including dental caries. Pediatric patients with leukemia are immunosuppressed;
therefore, prevention of the start or progression of oral disease is important in reducing
complications during treatment. Increased role of the pediatric dentist in the oral health and
prevention education and care of patients with leukemia could also play an important part in
decreasing risk for caries in patients undergoing cancer therapy and survivors. Although it is more
difficult to eliminate or minimize risk for some acute and long-term sequelae of cancer therapy,
dental caries is a preventable and common effect of therapy that may be addressed by increased
role of pediatric dental provider as a member of the oncology care team.
There is minimal prospective or randomized research regarding the dental provider’s
involvement in care of survivors of childhood cancer.31
Many of the previously suggested barriers are addressed in the proposed protocol,
including gaps in knowledge, reliance on tradition, diversity in oral care regimens and practices,
inconsistency of oral assessment, administrative and clinical issues, and lack of interdisciplinary
collaboration. One hundred percent of responding providers in the Department of Hematology
and Oncology were in agreement that the proposed protocol addressed a known problem for their
16

patients. None of the providers indicated they believed implementation would have a low impact
on their patients. Gaps in knowledge, especially of the patient and parent, would be lessened with
one-on-one prevention and supportive oral health education with the pediatric dental provider at
several points during treatment. Eighty-five percent of responding physicians identified
increased parent and patient knowledge as a strength of the protocol. The family would also have
an established relationship with a dental provider knowledgeable of the patient’s unique special
healthcare needs. The proposed protocol provides preventive and supportive oral care
recommendations based on a systematic review of most recent oncology literature and presented
as a guideline by the American Academy of Pediatric Dentistry. This minimizes reliance on
tradition and proposes an alternative to diverse oral care regimens and practices previously
noted. The protocol provides a schedule for follow up oral examination and review of preventive
and supportive recommendations and self-management goals which provides consistency of oral
assessment.
Administrative and clinical issues have also been mentioned as a barrier, particularly
limited time of the nurse or physician to address oral health amongst other responsibilities.25
Delegation of responsibilities to the pediatric dental provider would lessen the burden on current
members of the pediatric oncology care team and ensure more dedicated attention by one
provider to oral preventive and supportive care. None of the responding providers indicated that
a weakness of the proposed protocol was burden on the current provider. While 77% and 62%
indicated that a strength was simplicity of implementation and low burden on the current
provider respectively, this may be higher if there was a dental department and designated
provider within the cancer center. At VCU, pediatric dentistry serves as a consulting service so
current providers are responsible for notifying pediatric dentistry of new diagnoses and
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scheduling consultations. This may also explain why 23% of respondents identified time
required for implementation as a weakness. The 53% indicating that more training would be
necessary in order to implement is likely due to the assumption of assumed responsibility of
education, oral assessment, and salivary analysis in the absence of the pediatric dental provider.
Addition of the pediatric dentist addresses the recommended standard of interdisciplinary care of
pediatric oncology patients; 85% of respondents indicated that this was a strength of the
proposed protocol.
Limitations of this study are important to note. Feasibility agreement of providers in our
study may not be generalizable to other institutions. Providers already have an established, yet
limited relationship with pediatric dentistry and are thus more familiar with the idea of inclusion
of the pediatric dentist in multidisciplinary care of their patients. It is not uncommon for
physicians and nurses provide preventive and supportive oral health care. In a survey of
National Cancer Institute (NCI)- designated comprehensive cancer centers, 32% of responding
centers stated that physicians and nurses managed oral complications.23 This may represent an
optimistic view as centers that did not respond may have had less awareness of importance and
established support of oral health care during cancer therapy. In another survey of current
practice, nurses were responsible for oral health in 23% of responding cancer care centers.32 It
may be more difficult to implement the pediatric dentist’s role in centers without established
dental presence, which may be why NCI recommends that all cancer treatment centers have an
established dental department.23
If clinical effectiveness is demonstrated, this proposed protocol involving the pediatric
dentist as a member of the pediatric oncology patient’s care team throughout therapy may
contribute to a universal evidence-based guidelines and recommendations for oral health and
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prevention care. Oncology literature supports that the prevention and effective management of
oral and dental complications during therapy may improve oral function and quality of life and
decrease morbidity and cost of care.22 Seventy-seven percent of responding providers in the
Department of Pediatric Hematology and Oncology indicated the potential of the protocol to
improve patient quality of life. It may also provide support in the realization of the National
Cancer Institute’s recommendation that all cancer treatment centers have an established dental
department.23

19

Conclusion

The addition of the pediatric dentist to the pediatric oncology care team is warranted and
feasible.
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Tables

Table 1. Average Agreement with Statements Regarding Feasibility, Importance, and Value

It is feasible to incorporate this protocol into patient care.
It is important to address oral health during oncology
treatment.
Implementing this protocol would be a valuable addition to our
patients' care.
*2=Strongly Agree, -2=Strongly Disagree

Average
1.38

SD
0.65

1.77

0.44

1.62

0.51

Table 2. Strengths of Proposed Protocol as Indicated by Respondents
Strengths
Addresses a known problem for the patients
Simple to implement
Potential to improve patient quality of life
Increases parent and patient knowledge
Addition of pediatric dentist to the patient care team
Low burden on current providers
Other

24

n
%
13 100%
10 77%
10 77%
11 85%
11 85%
8 62%
2 15%

Table 3.Weaknesses of Proposed Protocol as Indicated by Respondents
Weaknesses
Burden on current providers
Time required for implementation
Low impact on patient
Quality of distributed patient education materials
More training would be necessary in order to
implement
Other

25

n
0
3
0
2

%
0%
23%
0%
15%

7
2

54%
15%

Figures
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Other

Burden on current Low impact on
providers
patient

Appendix
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CARIES CHARTING
SUBJECT NUMBER

SUBJECT INITIALS

_____ _____ _____

DATE OF VISIT

_____/ _____/_____

_____ _____ _____

Completed by: _______

7*4*5/6.#&3________
UR

UL

B
L
2

3

4
a

5
b

6
c

7
d

8
e

9
f

10
g

11
h

12
i

13
j

14

15

31

30

29
t

28
s

27
r

26
q

25
p

24
o

23
n

22
m

21
l

20
k

19

18

L
B

LL

LR
Examiner Signature: _______________________________________ Date: ______________

Surface Condition
0 not restored or sealed
1 sealant (partial)
2 sealant (full)
3 tooth colored restoration
4 amalgam
5 stainless steel crown
7 lost or broken restoration
8 temporary restoration

Activity
+ active lesion
- arrested lesion
Missing Codes
97 tooth missing due to caries
98 tooth missing for other reasons
99 tooth unerupted

Caries Code
0 sound enamel
A visual changes in enamel
B moderate decay
C extensive decay
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Confidential

Pediatric Hematology Oncology Questionnaire

Page 1 of 1

Please complete the survey below.

Thank you!
It is feasible to incorporate this protocol into patient care.
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
It is important to address oral health during oncology treatment.
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Implementing this protocol would be a valuable addition to our patients' care.
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Please select any of the following that you feel are strengths of this proposed protocol (Check all that apply).
Addresses a known problem for the patients
Simple to implement
Potential to improve patient quality of life
Increases parent and patient knowledge
Addition of pediatric dentist to the patient care team
Low burden on current providers
Other
Please specify any other strengths or suggestions:
__________________________________
Please select any of the following that you feel are areas for improvement with the proposed protocol (Check all that
apply).
Burden on current providers
Time required for implementation
Low impact on patient
Quality of distributed patient education materials
More training would be necessary in order to implement
Other
Please specify any other areas for improvement or suggestions:
__________________________________
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